Whether we spent our younger years making images appear by drawing lines between consecutive numbers or watching a movie about a genius piecing together a complex mystery, we have all been fascinated by connecting the dots. At Abbott, one way we fulfill this natural desire is by looking holistically at people, finding ways to combine leading-edge technologies to bring relief to those who need it most. For example, through our glucose monitoring products and chronic pain management innovations, we know some things about these challenges and how to work across disciplines to find solutions. Which is why we are excited to announce FDA approval for our Proclaim™ XR spinal cord stimulation (SCS) system to treat painful diabetic peripheral neuropathy (DPN), a serious complication of diabetes. If you are not familiar with painful DPN, that's good. It means you haven't experienced it.